US Stock MarketDetailed Quotes

VRPX Virpax Pharmaceuticals

Watchlist
  • 0.1900
  • -0.0085-4.28%
Close Mar 4 16:00 ET
  • 0.1813
  • -0.0087-4.58%
Post 19:59 ET
5.05MMarket Cap-0.07P/E (TTM)

About Virpax Pharmaceuticals Company

Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.

Company Profile

SymbolVRPX
Company NameVirpax Pharmaceuticals
Listing DateFeb 17, 2021
Issue Price10.00
Founded2017
CEOMr. Jatinder Dhaliwal
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address1055 Westlakes Drive,Suite 300
CityBerwyn
ProvincePennsylvania
CountryUnited States of America
Zip Code19312
Phone1-610-727-4597

Company Executives

  • Name
  • Position
  • Salary
  • Jatinder Dhaliwal
  • Director and Chief Executive Officer
  • --
  • Usama Chaudhry
  • Chief Financial Officer and Corporate Secretary
  • --
  • Dr. Sheila A. Mathias, J.D.,M.B.A.,PhD
  • Chief Scientific Officer
  • 498.00K
  • Katharyn Field
  • Director
  • --
  • Judy Su
  • Independent Director
  • --
  • Charn Deol
  • Independent Director
  • --
  • Esha Randhawa
  • Independent Director
  • --

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More